Workflow
Hunan Hengguang Technology (301118)
icon
Search documents
恒光股份股价涨5.18%,诺安基金旗下1只基金位居十大流通股东,持有62.55万股浮盈赚取82.57万元
Xin Lang Cai Jing· 2026-02-03 05:32
Group 1 - The core viewpoint of the news is that Hengguang Co., Ltd. experienced a stock price increase of 5.18%, reaching 26.78 CNY per share, with a trading volume of 115 million CNY and a turnover rate of 4.18%, resulting in a total market capitalization of 2.951 billion CNY [1] - Hengguang Co., Ltd. is located in Huaihua City, Hunan Province, and was established on December 18, 2008, with its listing date on November 18, 2021. The company's main business involves the research, production, and sales of sulfur and chlorine chemical product chains [1] - The revenue composition of Hengguang Co., Ltd. is as follows: 72.00% from chlorine chemical product chain, 27.77% from sulfur chemical product chain, and 0.23% from other supplementary sources [1] Group 2 - From the perspective of major circulating shareholders, the Noan Fund has a fund that ranks among the top ten circulating shareholders of Hengguang Co., Ltd. The Noan Multi-Strategy Mixed A Fund (320016) entered the top ten in the third quarter, holding 625,500 shares, which accounts for 0.6% of the circulating shares [2] - The Noan Multi-Strategy Mixed A Fund (320016) was established on August 9, 2011, with a latest scale of 2.12 billion CNY. Year-to-date returns are 8.06%, ranking 1008 out of 8874 in its category; the one-year return is 79.56%, ranking 370 out of 8124; and since inception, the return is 256.6% [2] - The fund manager of Noan Multi-Strategy Mixed A Fund is Kong Xianzheng, who has a cumulative tenure of 5 years and 70 days, with the total asset scale of 6.675 billion CNY. The best fund return during his tenure is 104.01%, while the worst is -16.74% [2]
恒光股份:预计2025年全年净亏损1000万元—2000万元
Core Viewpoint - Hengguang Co., Ltd. is forecasting a net profit attributable to shareholders of the listed company for 2025 to be between -20 million and -10 million yuan, indicating a continued loss but an improvement compared to the previous year [1] Group 1: Performance Forecast - The company expects a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -31 million and -21 million yuan for 2025 [1] - The anticipated loss for 2025 is expected to be less than the previous year due to a slight recovery in industry demand, leading to a modest increase in product prices and operating revenue [1] Group 2: Factors Influencing Performance - The increase in production capacity and sales volume of chlor-alkali products from the overseas base in Laos contributed to the improved performance compared to the previous year [1] - Significant factors impacting profits include a provision for asset impairment of approximately 40 million yuan and share-based payment expenses of about 12 million yuan during the reporting period [1] Group 3: Non-Recurring Gains and Losses - The company estimates that non-recurring gains and losses will impact the net profit attributable to shareholders by approximately 11 million yuan, compared to an actual amount of 18.08 million yuan in the same period last year [1]
恒光股份(301118) - 2025 Q4 - 年度业绩预告
2026-01-29 09:16
Financial Performance - The company expects a net profit in the range of -20 million to -10 million CNY for the year 2025, compared to -60.93 million CNY in the same period last year[4] - The net profit after deducting non-recurring gains and losses is projected to be between -31 million and -21 million CNY, down from -79.01 million CNY year-over-year[4] - The primary reasons for the reduced loss include a slight recovery in industry demand and an increase in sales prices, leading to higher operating revenue[7] - The estimated impact of non-recurring gains and losses on the net profit attributable to shareholders is about 11 million CNY, compared to 18.08 million CNY in the previous year[8] Production and Capacity - The overseas (Laos) base has further released capacity for caustic soda products, resulting in increased production and sales compared to the previous year[7] Asset Management - The company has recognized approximately 40 million CNY in asset impairment provisions during the reporting period[8] - An additional 12 million CNY has been accounted for as share-based payment expenses in the same period[8] Financial Reporting - The financial data presented is preliminary and has not been audited by the accounting firm[5] - Detailed financial data will be disclosed in the 2025 annual report[9] Investor Guidance - The company emphasizes the importance of rational investment and risk awareness for investors[9]
恒光股份1月22日获融资买入1127.44万元,融资余额7816.57万元
Xin Lang Cai Jing· 2026-01-23 01:33
Group 1 - The core viewpoint of the news is that Hengguang Co., Ltd. has shown significant trading activity and financial performance, with a notable increase in revenue and a decrease in shareholder numbers [1][2]. Group 2 - On January 22, Hengguang Co., Ltd. saw a stock price increase of 2.29%, with a trading volume of 154 million yuan. The financing buy amount was 11.27 million yuan, while the financing repayment was 12.44 million yuan, resulting in a net financing buy of -1.16 million yuan [1]. - As of January 22, the total financing and securities lending balance for Hengguang Co., Ltd. was 78.17 million yuan, with the financing balance accounting for 2.67% of the circulating market value, indicating a high level compared to the past year [1]. - The company specializes in the research, production, and sales of sulfur and chlorine chemical products, with the main business revenue composition being 72% from chlorine products and 27.77% from sulfur products [1]. Group 3 - As of September 30, the number of shareholders for Hengguang Co., Ltd. was 12,500, a decrease of 26.51% from the previous period, while the average circulating shares per person increased by 36.06% to 8,370 shares [2]. - For the period from January to September 2025, Hengguang Co., Ltd. achieved a revenue of 1.109 billion yuan, representing a year-on-year growth of 29.22%, while the net profit attributable to the parent company was -1.655 million yuan, showing a year-on-year increase of 96.92% [2]. - Since its A-share listing, Hengguang Co., Ltd. has distributed a total of 147 million yuan in dividends, with 67.135 million yuan distributed over the past three years [2].
恒光股份(301118) - 关于为全资子公司提供担保的进展公告
2026-01-20 07:45
鉴于近日全资子公司湖南恒光化工有限公司(以下简称"恒光化工")向中 国光大银行股份有限公司衡阳分行(以下简称"光大银行")申请综合授信事项 需要母公司提供担保,公司与光大银行签署了《最高额保证合同》(以下简称"保 证券代码:301118 证券简称:恒光股份 公告编号:2026-002 湖南恒光科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 湖南恒光科技股份有限公司(以下简称"公司"或"恒光股份")于 2025 年 11 月 24 日召开第五届董事会第十七次会议、于 2025 年 12 月 11 日召开 2025 年第四次临时股东大会,审议通过了《关于公司及子公司向金融机构申请综合授 信额度及担保额度的议案》,同意公司及子公司向银行等金融机构申请总额不超 过人民币 20 亿元的授信额度,授信使用额度不超过人民币 18 亿元,并由公司为 全资及控股子公司向银行等金融机构申请的授信提供不超过人民币 6 亿元的担 保,综合授信额度的申请期限和担保额度的授权期限均为自公司 2025 年第四次 临时股 ...
恒光股份(301118.SZ):湘江投资拟减持不超过2.99%股份
Ge Long Hui A P P· 2026-01-14 13:28
Core Viewpoint - Xiangjiang Industrial Investment Co., Ltd. plans to reduce its stake in Hengguang Co., Ltd. by up to 3.3 million shares, representing 2.99% of the total share capital, within a specified period [1] Group 1 - Shareholder Xiangjiang Investment currently holds 7,660,000 shares, accounting for 6.95% of the total share capital of the company [1] - The planned reduction will take place from February 5, 2026, to May 4, 2026, through centralized bidding or block trading [1] - The maximum number of shares to be sold is 3.3 million, which is less than 3% of the company's current total share capital [1]
恒光股份(301118) - 关于持股5%以上股东减持股份的预披露公告
2026-01-14 12:42
证券代码:301118 证券简称:恒光股份 公告编号:2026-001 湖南恒光科技股份有限公司 关于持股 5%以上股东减持股份的预披露公告 持股 5%以上的股东湘江产业投资有限责任公司保证向本公司提供的信息内 容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: 一、股东的基本情况 (一)股东名称:湘江产业投资有限责任公司 (二)股东持有股份的总数量:7,760,000股 (三)占公司总股本的比例:6.95% (四)根据《深圳证券交易所上市公司创业投资基金股东减持股份实施细则 (2020年修订)》中规定"第七条符合中国证监会相关规定且在中国证券投资基 金业协会备案的私募股权投资基金,参照本细则执行"; "第三条符合条件的创业投资基金,在其投资的早期企业、中小企业或高新 技术企业上市后,通过集中竞价交易方式减持其持有的首次公开发行前股份的, 适用下列比例限制:(四)截至首次公开发行上市日,投资期限已满六十个月的, 创业投资基金减持股份总数不受比例限制"; "第四条符合条件的创业投资基金,在其投资的早期企业、中小企业或高新 技术 ...
恒光股份:恒光化工高纯锗相关产品生产线已停止生产
Mei Ri Jing Ji Xin Wen· 2025-12-25 13:47
Group 1 - The company has halted the production line for high-purity germanium products due to export controls and changes in market conditions [2] - Currently, the company does not have any share repurchase plans, but will disclose any future plans as required [2]
恒光股份12月23日获融资买入3642.98万元,融资余额1.13亿元
Xin Lang Cai Jing· 2025-12-24 01:36
Group 1 - The core viewpoint of the news is that Hengguang Co., Ltd. has shown significant trading activity and financial performance, with a notable increase in revenue and changes in shareholder structure [1][2][3] Group 2 - On December 23, Hengguang Co., Ltd. saw a stock price increase of 1.06%, with a trading volume of 302 million yuan. The margin trading data indicates a net buying of 12.79 million yuan on that day, with a total margin balance of 113 million yuan, representing 4.06% of the market capitalization [1] - As of September 30, the number of shareholders for Hengguang Co., Ltd. was 12,500, a decrease of 26.51% from the previous period, while the average circulating shares per person increased by 36.06% to 8,370 shares [2] - For the period from January to September 2025, Hengguang Co., Ltd. achieved an operating income of 1.109 billion yuan, reflecting a year-on-year growth of 29.22%. However, the net profit attributable to the parent company was -1.655 million yuan, showing a significant year-on-year improvement of 96.92% [2] - Since its A-share listing, Hengguang Co., Ltd. has distributed a total of 147 million yuan in dividends, with 67.135 million yuan distributed over the past three years [3] - As of September 30, 2025, among the top ten circulating shareholders, the Noan Multi-Strategy Mixed A fund is the fifth largest shareholder, holding 625,500 shares as a new investor [3]
恒光股份:湘江投资已减持0.54%股份
南财智讯12月22日电,恒光股份公告,持股5%以上股东湘江产业投资有限责任公司(简称"湘江投 资")在2025年9月24日至2025年11月19日期间,通过集中竞价方式合计减持公司股份60万股,占公司总 股本的0.54%,减持均价为28.46元/股。本次减持后,湘江投资持有公司股份766万股,占总股本的 6.95%。本次减持计划实施情况与此前披露一致,未导致公司控制权变更,不影响公司持续经营。 ...